The present study indicates that patients affected by NAFLD have elevated levels of CRP, fibrinogen, PAI-1, von Willebrand factors, and F VII, which are known to be associated with an increased risk of thrombosis. The gene discussed is VWF; the disease is metabolic dysfunction-associated steatotic liver disease.